Latest news with #healthagencies
Yahoo
18-07-2025
- Health
- Yahoo
Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR
DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2032, culminating in a forecasted valuation of US$11.6 billion by the end of the period. The sleep apnea devices market is experiencing significant growth, primarily driven by the increasing integration of telemedicine, mobile health (mHealth), and artificial intelligence in the diagnostic and therapeutic processes for sleep apnea. The expansion of key market players into emerging economies like India, Australia, the UAE, and Saudi Arabia is further enhancing this market's potential. Additionally, there is a notable trend among health agencies to expand reimbursement policies for remote patient monitoring and related connected healthcare services, which is improving accessibility to advanced sleep apnea management solutions. Furthermore, innovative developments such as compact positive airway pressure (PAP) devices and wearable sleep monitoring technologies are gaining traction, reshaping the dynamics of the sleep apnea devices market. Download PDF Brochure: Browse in-depth TOC on 'Sleep Apnea Devices Market' 739 - Tables51 - Figures497 - Pages By product type, the sleep apnea devices market is categorized into two main product types: therapeutic devices and diagnostic devices. In 2024, the therapeutic devices segment emerged as the dominant player in the market, capturing the largest share. This growth can be attributed to continuous advancements in technology focused on increasing patient comfort and enhancing the overall user experience, which in turn fosters better adherence to therapy. Leading the charge in this segment are prominent companies such as ResMed from the United States, Koninklijke Philips N.V. based in the Netherlands, and Fisher & Paykel Healthcare Limited from New Zealand, all of which are renowned for their innovative solutions in the field of sleep apnea management. By end users, the sleep apnea devices market is segmented by end user into several categories, including hospitals, home care settings, sleep clinics, ambulatory care centers, primary care centers, and other specialized end users. As we look ahead to 2024, it is anticipated that home care settings and individual users will dominate the market, capturing the largest share. This trend can be attributed to a growing preference for home-based diagnosis and treatment options, which effectively eliminates the need for patients to travel to sleep centers for their care. The convenience of being able to monitor and manage sleep apnea from the comfort of one's home has significantly enhanced the accessibility of these devices. This shift not only appeals to patients seeking a more comfortable treatment experience but also addresses the ongoing demand for efficient and timely care in the face of increasing patient volumes. Ultimately, these factors collaborate to drive substantial growth in the market for sleep apnea devices. By geography, the global market for sleep apnea devices has been segmented into six major geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America stood out as the largest market for sleep apnea devices in 2024. Several factors contribute to North America's market leadership. Firstly, there is a high level of public awareness regarding sleep apnea and its associated health risks, which encourages individuals to seek diagnosis and treatment. Additionally, the region boasts widespread access to advanced diagnostic technologies, enabling healthcare providers to accurately identify sleep apnea cases and recommend appropriate devices. Moreover, favorable reimbursement policies play a significant role in facilitating the adoption of these medical devices. Insurers are increasingly covering expenses related to sleep apnea treatments, making it more financially viable for patients to invest in devices that improve their quality of sleep and overall health. As a result, the combination of heightened awareness, access to cutting-edge technology, and supportive healthcare policies has led to a notable increase in the adoption of sleep apnea devices throughout North America. Request Sample Pages: The major players operating in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Löwenstein Medical SE & Co. KG (Germany), Drive DeVilbiss International (US), BMC (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Holdings Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. KG (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US) ResMed (US): In 2024, ResMed, a leading company based in the United States, captured the largest market share in the global sleep apnea devices sector. The company has built a strong reputation for its innovative and highly effective therapeutic and diagnostic solutions, particularly in sleep health. ResMed's success is primarily attributed to its extensive expertise in healthcare technology, which allows it to develop sleep apnea devices that deliver both accuracy and efficacy in treatment. Over the past few years, ResMed has significantly broadened its product portfolio, focusing on positive airway pressure (PAP) devices and facial interfaces that enhance user comfort and compliance. This expansion diversifies its offerings and positions ResMed to meet broader patient needs and preferences. By continually advancing its technology and product design, the company has maintained its status as the market leader in sleep apnea solutions. It is committed to improving patient outcomes and quality of life. Koninklijke Philips N.V. (Netherlands) Koninklijke Philips N.V., headquartered in the Netherlands, was the second-largest company in market share in 2024. Renowned for its expertise in the sleep apnea sector, Philips has established itself as a vital contributor to health monitoring and respiratory care. The company has gained recognition for its innovative and user-centric devices designed to enhance the quality of life for individuals suffering from sleep apnea. In recent years, Philips has sought to expand its global presence through strategic partnerships and acquisitions. These initiatives aim to improve accessibility to sleep apnea solutions and increase awareness about the condition, particularly in emerging and developing markets where health challenges are often underrecognized. By aligning with local healthcare providers and leveraging regional insights, Philips is working to ensure that effective treatment options reach a wider audience, contributing to better overall health outcomes for sleep apnea patients. Fisher & Paykel Healthcare Limited (New Zealand) Fisher & Paykel Healthcare Limited, based in New Zealand, is anticipated to capture the third-largest market share of sleep apnea devices by 2024. The company strategically distributes its innovative sleep apnea products across two primary segments: the Hospital and Homecare sectors. Fisher & Paykel is committed to elevating patient care by continuously enhancing its product offerings, emphasizing advanced humidification systems and state-of-the-art mask technologies. These improvements are designed to improve patient comfort during therapy and optimize therapeutic outcomes, ensuring that users experience effective and comfortable treatment for their sleep apnea. Through these efforts, the company aims to solidify its position as a leader in the sleep apnea market while improving the quality of life for patients globally. For more information, Inquire Now! Related Reports: Pulse Oximeter Market Patient Monitoring Devices Market Home Healthcare Market Respiratory Care Devices Market Top 10 Medical Device Technologies Market Get access to the latest updates on Sleep Apnea Devices Companies and Sleep Apnea Devices Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Independent
10-07-2025
- Climate
- The Independent
Temperatures to reach 31C as health alert extended across England
England is experiencing its third heatwave of the summer, with a yellow heat health alert now extended across all regions. Temperatures are forecast to reach 31C on Thursday, potentially climbing to 33C in London by Saturday, with hot conditions expected to last through the weekend. Scotland is also anticipated to meet its heatwave threshold, requiring 28C in the south and 25C in the north for three consecutive days. Forecasters predict this heatwave will be longer and cover a broader area than the one in early July, though not as intense. Health agencies and safety organisations advise staying hydrated, seeking shade, using sunscreen, and exercising caution with water activities and barbecues, while drivers are urged to check their vehicles.
CNN
09-07-2025
- Health
- CNN
Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone
The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the disease was declared eliminated a quarter-century ago, just as a key Senate committee split the vote to advance President Donald Trump's nominee to lead the public health agency. There have been more measles cases in the US this year than any other since the disease was declared eliminated a quarter-century ago, according to CDC data, with at least 1,288 confirmed cases. Just halfway through the year, the case tally has already surpassed the previous record from 2019, when there were a total of 1,274 cases. And it's well above the average of about 180 measles cases that have been reported each year since the disease was declared eliminated in the US in 2000. CNN reported this new milestone on Saturday using data from the Johns Hopkins University Center for Outbreak Response Innovation, which updates its numbers more frequently than the CDC. HHS has not responded to CNN's request for comment about the measles milestone. Childhood vaccine coverage has been declining in the US, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the CDC. When the measles case count reached its previous record in 2019 – during the first Trump administration – both the CDC director and the secretary of the US Department of Health and Human Services at the time released statements emphasizing the safety and effectiveness of the measles-mumps-rubella (MMR) vaccine and encouraging Americans to get vaccinated. However, almost six months into Trump's second term, the CDC still does not have a director and HHS Secretary Robert F. Kennedy Jr. has a long and complicated history with measles vaccines. HHS said in a statement Wednesday that the agency 'continues to support community efforts in dealing with the measles outbreaks' and 'CDC continues to provide technical assistance, laboratory support, and vaccines as requested.' The statement did not specifically address the new measles milestone, instead noting population-level case rates and echoing language that Kennedy has used about vaccines. 'CDC continues to recommend MMR vaccines as the best way to protect against measles. The decision to vaccinate is a personal one,' the statement said. 'People should consult with their healthcare provider to understand their options to get inoculated and should be informed about the potential risks and benefits associated with vaccines.' Concerns about vaccine skepticism were front and center Wednesday as members of the Senate Health, Education, Labor and Pensions Committee voted to advance President Donald Trump's nominee to lead the CDC, Dr. Susan Monarez, for a vote by the full Senate. Committee members voted 12-11 to move Monarez's nomination. All of the committee's Republicans backed the longtime immunologist and government scientist, who spoke in her confirmation hearing about restoring trust in the CDC and defended Kennedy's decision to replace the members of a federal panel of vaccine advisers. The vote puts Monarez one step closer to taking the helm at the public health agency, and she will now progress to a full Senate vote. HELP Chairman Sen. Bill Cassidy, a Louisiana Republican and a doctor, voted to advance Monarez's nomination but nodded to falling vaccine coverage and the ongoing measles outbreak. 'Dr. Monarez will work to modernize our data health systems, to improve public health coordination and response while protecting American sensitive health information,' Cassidy said. 'This is especially crucial as the nation combats reemerging public health threats like measles, which has taken three lives in the United States this year.' He continued: 'One that's not included but is tragic: A Canadian woman who was pregnant got exposed to measles and lost her child. [The ongoing outbreak has] hospitalized many more due to misinformation regarding the measles vaccine.' Cassidy publicly pressed Kennedy last month to delay a meeting of the health agency's new vaccine advisers — several of whom have expressed skepticism and safety concerns about long-approved immunizations — amid concerns about their biases. During Wednesday's meeting, Sen. Patty Murray, a Washington Democrat, called on the committee to hold a hearing about the ongoing measles outbreak and Kennedy's shakeup of vaccine oversight. 'I am concerned because this committee, it feels like, has all but abandoned its serious oversight of this crisis,' she said. 'We haven't had a hearing on the record-breaking number of measles outbreaks or a hearing on how the CDC vaccine panel is now stacked with people who are actually not vetted, and all the previous board members, every single one of them, was removed with no credible explanation.' There needs to be congressional oversight of these actions, Murray said after casting a vote against Monarez. 'I really do hope that Dr. Monarez will defy my expectations. I hope she will stand up for science and put public health first. But again, I hope I have hoped that for others, and here we are today,' she said. Some health experts have emphasized the importance of vaccination rates and their trepidation about precedents being set under Kennedy's leadership of HHS. 'It is no surprise that the most widespread measles outbreak affecting the United States in a generation has occurred under Secretary Kennedy's watch,' Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, said in a statement Wednesday. 'His decades-long campaign to discredit vaccines at every turn, which has continued unabated during his time as health secretary, directly contributes to the alarming decline in routine childhood vaccination rates in our country that is resulting in more frequent outbreaks of vaccine-preventable diseases,' he said. 'In addition, the dramatic funding cuts to public health will mean that small outbreaks will grow and spread.' Three people have died of measles in the US this year – two children in Texas and one adult in New Mexico, all of whom were unvaccinated – matching the total number of US measles deaths from the previous two and a half decades. 'I worry that even more children will be forced to pay with their lives or health because of Secretary Kennedy's malfeasance,' Besser said. 'As a pediatrician, I strongly encourage all parents to talk to their healthcare providers, listen to their local public health officials, and learn the facts about measles vaccines, which are incredibly effective and safe.' The MMR vaccine is highly effective. One dose offers 93% protection against measles, and two doses are 97% effective, according to the CDC. 'Vaccines work—full stop. They are one of the most powerful tools we have to protect patients, families and entire communities. We can prevent diseases through vaccines, but too many diseases that we once had under control are starting to reappear because people are choosing to delay or skip immunization,' Dr. Jennifer Brull, president of the American Academy of Family Physicians, said in a statement. 'There's a lot of confusion around vaccinations, but patients don't have to navigate this alone. Family physicians, pediatricians, pharmacists and other public health workers can help patients wade through all the information and cut through the noise,' she said. 'The bottom line is vaccines are safe, effective and save lives. It's critical that we continue to protect not just individual families, but the health of our entire nation.'
CNN
09-07-2025
- Health
- CNN
Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone
The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the disease was declared eliminated a quarter-century ago, just as a key Senate committee split the vote to advance President Donald Trump's nominee to lead the public health agency. There have been more measles cases in the US this year than any other since the disease was declared eliminated a quarter-century ago, according to CDC data, with at least 1,288 confirmed cases. Just halfway through the year, the case tally has already surpassed the previous record from 2019, when there were a total of 1,274 cases. And it's well above the average of about 180 measles cases that have been reported each year since the disease was declared eliminated in the US in 2000. CNN reported this new milestone on Saturday using data from the Johns Hopkins University Center for Outbreak Response Innovation, which updates its numbers more frequently than the CDC. HHS has not responded to CNN's request for comment about the measles milestone. Childhood vaccine coverage has been declining in the US, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the CDC. When the measles case count reached its previous record in 2019 – during the first Trump administration – both the CDC director and the secretary of the US Department of Health and Human Services at the time released statements emphasizing the safety and effectiveness of the measles-mumps-rubella (MMR) vaccine and encouraging Americans to get vaccinated. However, almost six months into Trump's second term, the CDC still does not have a director and HHS Secretary Robert F. Kennedy Jr. has a long and complicated history with measles vaccines. Concerns about vaccine skepticism were front and center Wednesday as members of the Senate Health, Education, Labor and Pensions Committee voted to advance President Donald Trump's nominee to lead the CDC, Dr. Susan Monarez, for a vote by the full Senate. Committee members voted 12-11 to move Monarez's nomination. All of the committee's Republicans backed the longtime immunologist and government scientist, who spoke in her confirmation hearing about restoring trust in the CDC and defended Kennedy's decision to replace the members of a federal panel of vaccine advisers. The vote puts Monarez one step closer to taking the helm at the public health agency, and she will now progress to a full Senate vote. HELP Chairman Sen. Bill Cassidy, a Louisiana Republican and a doctor, voted to advance Monarez's nomination but nodded to falling vaccine coverage and the ongoing measles outbreak. 'Dr. Monarez will work to modernize our data health systems, to improve public health coordination and response while protecting American sensitive health information,' Cassidy said. 'This is especially crucial as the nation combats reemerging public health threats like measles, which has taken three lives in the United States this year.' He continued: 'One that's not included but is tragic: A Canadian woman who was pregnant got exposed to measles and lost her child. [The ongoing outbreak has] hospitalized many more due to misinformation regarding the measles vaccine.' Cassidy publicly pressed Kennedy last month to delay a meeting of the health agency's new vaccine advisers — several of whom have expressed skepticism and safety concerns about long-approved immunizations — amid concerns about their biases. During Wednesday's meeting, Sen. Patty Murray, a Washington Democrat, called on the committee to hold a hearing about the ongoing measles outbreak and Kennedy's shakeup of vaccine oversight. 'I am concerned because this committee, it feels like, has all but abandoned its serious oversight of this crisis,' she said. 'We haven't had a hearing on the record-breaking number of measles outbreaks or a hearing on how the CDC vaccine panel is now stacked with people who are actually not vetted, and all the previous board members, every single one of them, was removed with no credible explanation.' There needs to be congressional oversight of these actions, Murray said after casting a vote against Monarez. 'I really do hope that Dr. Monarez will defy my expectations. I hope she will stand up for science and put public health first. But again, I hope I have hoped that for others, and here we are today,' she said. Some health experts have emphasized the importance of vaccination rates and their trepidation about precedents being set under Kennedy's leadership of HHS. 'It is no surprise that the most widespread measles outbreak affecting the United States in a generation has occurred under Secretary Kennedy's watch,' Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, said in a statement Wednesday. 'His decades-long campaign to discredit vaccines at every turn, which has continued unabated during his time as health secretary, directly contributes to the alarming decline in routine childhood vaccination rates in our country that is resulting in more frequent outbreaks of vaccine-preventable diseases,' he said. 'In addition, the dramatic funding cuts to public health will mean that small outbreaks will grow and spread.' Three people have died of measles in the US this year – two children in Texas and one adult in New Mexico, all of whom were unvaccinated – matching the total number of US measles deaths from the previous two and a half decades. 'I worry that even more children will be forced to pay with their lives or health because of Secretary Kennedy's malfeasance,' Besser said. 'As a pediatrician, I strongly encourage all parents to talk to their healthcare providers, listen to their local public health officials, and learn the facts about measles vaccines, which are incredibly effective and safe.' The MMR vaccine is highly effective. One dose offers 93% protection against measles, and two doses are 97% effective, according to the CDC. 'Vaccines work—full stop. They are one of the most powerful tools we have to protect patients, families and entire communities. We can prevent diseases through vaccines, but too many diseases that we once had under control are starting to reappear because people are choosing to delay or skip immunization,' Dr. Jennifer Brull, president of the American Academy of Family Physicians, said in a statement. 'There's a lot of confusion around vaccinations, but patients don't have to navigate this alone. Family physicians, pediatricians, pharmacists and other public health workers can help patients wade through all the information and cut through the noise,' she said. 'The bottom line is vaccines are safe, effective and save lives. It's critical that we continue to protect not just individual families, but the health of our entire nation.'
CNN
09-07-2025
- Health
- CNN
Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone
The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the disease was declared eliminated a quarter-century ago, just as a key Senate committee split the vote to advance President Donald Trump's nominee to lead the public health agency. There have been more measles cases in the US this year than any other since the disease was declared eliminated a quarter-century ago, according to CDC data, with at least 1,288 confirmed cases. Just halfway through the year, the case tally has already surpassed the previous record from 2019, when there were a total of 1,274 cases. And it's well above the average of about 180 measles cases that have been reported each year since the disease was declared eliminated in the US in 2000. CNN reported this new milestone on Saturday using data from the Johns Hopkins University Center for Outbreak Response Innovation, which updates its numbers more frequently than the CDC. HHS has not responded to CNN's request for comment about the measles milestone. Childhood vaccine coverage has been declining in the US, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the CDC. When the measles case count reached its previous record in 2019 – during the first Trump administration – both the CDC director and the secretary of the US Department of Health and Human Services at the time released statements emphasizing the safety and effectiveness of the measles-mumps-rubella (MMR) vaccine and encouraging Americans to get vaccinated. However, almost six months into Trump's second term, the CDC still does not have a director and HHS Secretary Robert F. Kennedy Jr. has a long and complicated history with measles vaccines. Concerns about vaccine skepticism were front and center Wednesday as members of the Senate Health, Education, Labor and Pensions Committee voted to advance President Donald Trump's nominee to lead the CDC, Dr. Susan Monarez, for a vote by the full Senate. Committee members voted 12-11 to move Monarez's nomination. All of the committee's Republicans backed the longtime immunologist and government scientist, who spoke in her confirmation hearing about restoring trust in the CDC and defended Kennedy's decision to replace the members of a federal panel of vaccine advisers. The vote puts Monarez one step closer to taking the helm at the public health agency, and she will now progress to a full Senate vote. HELP Chairman Sen. Bill Cassidy, a Louisiana Republican and a doctor, voted to advance Monarez's nomination but nodded to falling vaccine coverage and the ongoing measles outbreak. 'Dr. Monarez will work to modernize our data health systems, to improve public health coordination and response while protecting American sensitive health information,' Cassidy said. 'This is especially crucial as the nation combats reemerging public health threats like measles, which has taken three lives in the United States this year.' He continued: 'One that's not included but is tragic: A Canadian woman who was pregnant got exposed to measles and lost her child. [The ongoing outbreak has] hospitalized many more due to misinformation regarding the measles vaccine.' Cassidy publicly pressed Kennedy last month to delay a meeting of the health agency's new vaccine advisers — several of whom have expressed skepticism and safety concerns about long-approved immunizations — amid concerns about their biases. During Wednesday's meeting, Sen. Patty Murray, a Washington Democrat, called on the committee to hold a hearing about the ongoing measles outbreak and Kennedy's shakeup of vaccine oversight. 'I am concerned because this committee, it feels like, has all but abandoned its serious oversight of this crisis,' she said. 'We haven't had a hearing on the record-breaking number of measles outbreaks or a hearing on how the CDC vaccine panel is now stacked with people who are actually not vetted, and all the previous board members, every single one of them, was removed with no credible explanation.' There needs to be congressional oversight of these actions, Murray said after casting a vote against Monarez. 'I really do hope that Dr. Monarez will defy my expectations. I hope she will stand up for science and put public health first. But again, I hope I have hoped that for others, and here we are today,' she said. Some health experts have emphasized the importance of vaccination rates and their trepidation about precedents being set under Kennedy's leadership of HHS. 'It is no surprise that the most widespread measles outbreak affecting the United States in a generation has occurred under Secretary Kennedy's watch,' Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, said in a statement Wednesday. 'His decades-long campaign to discredit vaccines at every turn, which has continued unabated during his time as health secretary, directly contributes to the alarming decline in routine childhood vaccination rates in our country that is resulting in more frequent outbreaks of vaccine-preventable diseases,' he said. 'In addition, the dramatic funding cuts to public health will mean that small outbreaks will grow and spread.' Three people have died of measles in the US this year – two children in Texas and one adult in New Mexico, all of whom were unvaccinated – matching the total number of US measles deaths from the previous two and a half decades. 'I worry that even more children will be forced to pay with their lives or health because of Secretary Kennedy's malfeasance,' Besser said. 'As a pediatrician, I strongly encourage all parents to talk to their healthcare providers, listen to their local public health officials, and learn the facts about measles vaccines, which are incredibly effective and safe.' The MMR vaccine is highly effective. One dose offers 93% protection against measles, and two doses are 97% effective, according to the CDC. 'Vaccines work—full stop. They are one of the most powerful tools we have to protect patients, families and entire communities. We can prevent diseases through vaccines, but too many diseases that we once had under control are starting to reappear because people are choosing to delay or skip immunization,' Dr. Jennifer Brull, president of the American Academy of Family Physicians, said in a statement. 'There's a lot of confusion around vaccinations, but patients don't have to navigate this alone. Family physicians, pediatricians, pharmacists and other public health workers can help patients wade through all the information and cut through the noise,' she said. 'The bottom line is vaccines are safe, effective and save lives. It's critical that we continue to protect not just individual families, but the health of our entire nation.'
